Search For "clinical"
COVID-19: MSN Laboratories initiates Phase III clinical trial of Molnupira
Updated : 4 years, 10 months ago IST
New Delhi [India], May 26 (ANI): MSN Laboratories Private Limited (MSN) is initiating phase III clinical trial of Molnupiravir capsules for the treatment of COVID-19 in India.
Read More
Optimus Pharma gets DCGI nod for conducting Phase III Clinical Trials for
Updated : 4 years, 10 months ago IST
Hyderabad (Telangana) [India], May 25 (ANI/PRNewswire): Optimus Pharma on the 19th of May 2021 received DCGI nod for conducting Phase III Clinical Trials for orally administered Molnupiravir capsules on patients with Mild to Moderate Covid-19 patients.
Read More
Mexico to conduct clinical trials of Walvax, Sanofi Vaccines: Foreign Secr
Updated : 4 years, 10 months ago IST
Mexico City [Mexico], May 25 (ANI/Sputnik): Mexico intends to conduct clinical trials of vaccines against COVID-19 developed by China's Walvax and France's Sanofi, Foreign Secretary Marcelo Ebrard said.
Read More
Bengaluru-based start-up develops ELISA test for accurate detection of COV
Updated : 4 years, 10 months ago IST
New Delhi [India], May 22 (ANI): A Bangalore-based start-up has developed a novel, point-of-care Electrochemical ELISA test to estimate accurate antibody concentration of COVID-19 in clinical samples, informed the Union Science and Technology Ministry on Saturday.
Read More
DST funded start-up's ELISA test to better estimate COVID 19 antibody conc
Updated : 4 years, 10 months ago IST
New Delhi [India], May 22 (ANI): A Department of Science and Technology (DST) supported technology-- Electrochemical ELISA test -- enables fast and accurate estimation of antibody concentration of COVID-19 in clinical samples, Ministry of Science and Technology said on Saturday.
Read More
COVID patients should take jab after 3 months of recovery: Expert panel
Updated : 4 years, 10 months ago IST
New Delhi [India], May 19 (ANI): The National Expert Group on Vaccine Administration for COVID-19 (NEGVAC) on Wednesday recommended that the COVID vaccination should be deferred by three months after clinical recovery of the illness.
Read More
Drugs manufacturer from Hyderabad on overdrive
Updated : 4 years, 10 months ago IST
Hyderabad (Telangana) [India], May 19 (ANI/PNN): Optimus Pharma on Tuesday received DCGI nod for conducting Phase III Clinical Trials for orally administered Molnupiravir capsules on patients with Mild and Moderate Covid-19 symptoms.
Read More
Delhi HC refuses to put stay on Phase 2-3 clinical trials of Covaxin for 2
Updated : 4 years, 10 months ago IST
New Delhi [India], May 19 (ANI): The Delhi High Court on Wednesday refused to put an interim stay on Phase 2-3 clinical trials of Covaxin COVID-19 vaccine for the 2-18 age group.
Read More
Quash notification allowing phase 2/3 trials of Covaxin in 2-18 years age
Updated : 4 years, 10 months ago IST
New Delhi [India], May 18 (ANI): A Public Interest Litigation (PIL) has been moved in Delhi High Court seeking quashing of Centre's "notification" of May 13, which has accorded permission for conduct of phase two/three clinical trials of Covaxin in the age group 2 to 18 years to its manuf
Read More
Covaxin phase II/III clinical trials for 2-18 age group to begin in 10-12
Updated : 4 years, 10 months ago IST
New Delhi [India], May 18 (ANI): Bharat Biotech is set to begin the phase II and III clinical trials for COVID-19 vaccine Covaxin in children in the age group of 2 to 18 years in the next 10-12 days, informed VK Paul, Member (Health), Niti Aayog on Tuesday.
Read More
Plasma therapy dropped from ICMR COVID-19 treatment protocols
Updated : 4 years, 10 months ago IST
New Delhi [India], May 18 (ANI): The use of convalescent plasma has been dropped from the recommended treatment protocols for COVID-19, according to the latest guidelines released by the Indian Council of Medical Research (ICMR) on Monday.
Read More
Cardiologist leads commission to help reduce burden of women's heart disea
Updated : 4 years, 10 months ago IST
New York [US], May 17 (ANI): A unique commission that issued major new recommendations aimed at fully understanding and reducing the global burden of heart disease in women was led by Roxana Mehran, MD, Professor of Medicine, and Population Health Science and Policy, and Director of Interven
Read More